Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05189938 · ClinicalTrials.gov registry record
HbA1c Variation Study
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 488
- Enrollment target
NCT05189938: Completed study, sponsored by Abbott Diabetes Care.
NCT05189938 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 488 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05189938 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 488 participants
- Enrollment target
Study Summary
To evaluate the relationship between glycated hemoglobin (HbA1c) and average glucose levels using continuous glucose monitoring.
Primary Outcome
This is an observational data collection study, where the goal is to gather data to establish the relationship between laboratory-derived HbA1c and average glucose levels.
Interventions
- DIAGNOSTIC_TEST HBA1c data and glucose levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2021-12-20 |
| Est. Completion | 2023-12-30 |
What the finished NCT05189938 record still lists
NCT05189938 is an observational study that tracks outcomes without assigning an intervention. The registered 488 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which HBA1c data and glucose levels is the first listed.
NCT05189938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05189938 about?
NCT05189938 is a clinical study titled "HbA1c Variation Study". To evaluate the relationship between glycated hemoglobin (HbA1c) and average glucose levels using continuous glucose monitoring.
What is the current status of trial NCT05189938?
This trial is currently completed. The enrollment target is 488 participants. The study started on 2021-12-20. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT05189938?
The interventions under investigation include: HBA1c data and glucose levels (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05189938?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05154669 · 488 participants · Phase 3
Integrating Financial Coaching and Smoking Cessation Coaching
- NCT06532877 · 488 participants · NA
Telephone Support in Advanced Gastrointestinal Cancer
- NCT06602479 · 488 participants · Phase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- NCT06794983 · 488 participants · NA
Calls and Coordination for Transitions of Care at Re-entry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI